23andme has goldmine of genetic data to auction, but few safeguards govern its sale
23andMe’s most valuable asset is a trove of genomic and biometric data from some 15 million people, which the company plans to sell off to the highest bidder. While the company...To view the full article, register now.
Already a subscriber? Click here to view full article